{"id":"https://openalex.org/W201280849","doi":"https://doi.org/10.1182/blood.v80.6.1430.1430","title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial","display_name":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial","publication_year":1992,"publication_date":"1992-09-15","ids":{"openalex":"https://openalex.org/W201280849","doi":"https://doi.org/10.1182/blood.v80.6.1430.1430","mag":"201280849","pmid":"https://pubmed.ncbi.nlm.nih.gov/1381626"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v80.6.1430.1430","doi":"https://doi.org/10.1182/blood.v80.6.1430.1430","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v80.6.1430.1430","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/80/6/1430/225970/1430.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051999451","display_name":"Ruth Pettengell","orcid":"https://orcid.org/0000-0001-9948-660X","observed_orcids":["https://orcid.org/0000-0001-9948-660X"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Pettengell","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041526616","display_name":"Howard Gurney","orcid":"https://orcid.org/0000-0003-0217-5261","observed_orcids":["https://orcid.org/0000-0003-0217-5261"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H Gurney","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011398209","display_name":"John A. Radford","orcid":"https://orcid.org/0000-0001-7898-2786","observed_orcids":["https://orcid.org/0000-0001-7898-2786"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"JA Radford","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108466152","display_name":"David P. Deakin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"DP Deakin","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113717535","display_name":"R.D. James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R James","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114022251","display_name":"Peter M. Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"PM Wilkinson","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K Kane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K Kane","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112293616","display_name":"J. Bentley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Bentley","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111377544","display_name":"Derek Crowther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D Crowther","raw_affiliation_strings":["Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":13.5793,"has_fulltext":true,"cited_by_count":440,"citation_normalized_percentile":{"value":0.99024433,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"80","issue":"6","first_page":"1430","last_page":"1436"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12919","display_name":"Blood disorders and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/high-grade-lymphoma","display_name":"high-grade lymphoma","score":0.8270000219345093},{"id":"https://openalex.org/keywords/chemotherapy-induced-neutropenia","display_name":"chemotherapy-induced neutropenia","score":0.6190000176429749},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8659999966621399},{"id":"https://openalex.org/keywords/infection-control","display_name":"infection control","score":0.7839999794960022},{"id":"https://openalex.org/keywords/ketoconazole","display_name":"ketoconazole","score":0.9120000004768372},{"id":"https://openalex.org/keywords/trimethoprim-sulfamethoxazole","display_name":"trimethoprim-sulfamethoxazole","score":0.9509999752044678},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.5210000276565552},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.6269999742507935},{"id":"https://openalex.org/keywords/vascular-mortality","display_name":"vascular death","score":0.4020000100135803},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8765512108802795},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.8246724605560303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6939663290977478},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.657257080078125},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.6508734822273254},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6367045640945435},{"id":"https://openalex.org/C74133956","wikidata":"https://www.wikidata.org/wiki/Q4669824","display_name":"Absolute neutrophil count","level":4,"score":0.582749605178833},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4730336368083954},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4667081832885742},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4328191876411438},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.41871291399002075},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.41831234097480774}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017053","descriptor_name":"Infection Control","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017053","descriptor_name":"Infection Control","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017053","descriptor_name":"Infection Control","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1182/blood.v80.6.1430.1430","doi":"https://doi.org/10.1182/blood.v80.6.1430.1430","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v80.6.1430.1430","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v80.6.1430.bloodjournal8061430","doi":"https://doi.org/10.1182/blood.v80.6.1430.bloodjournal8061430","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v80.6.1430.bloodjournal8061430","pdf_url":"https://ashpublications.org/blood/article-pdf/80/6/1430/225970/1430.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:1381626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1381626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/4fed847c-df37-4cdc-82ed-88c55c529958","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/4fed847c-df37-4cdc-82ed-88c55c529958","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pettengell, R, Gurney, H, Radford, J A, Deakin, D P, James, R, Wilkinson, P M, Kane, K, Bentley, J & Crowther, D 1992, 'Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial.', Blood, vol. 80, no. 6.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1182/blood.v80.6.1430.bloodjournal8061430","doi":"https://doi.org/10.1182/blood.v80.6.1430.bloodjournal8061430","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood.v80.6.1430.bloodjournal8061430","pdf_url":"https://ashpublications.org/blood/article-pdf/80/6/1430/225970/1430.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W201280849.pdf","grobid_xml":"https://content.openalex.org/works/W201280849.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W136355804","https://openalex.org/W184894832","https://openalex.org/W1537855173","https://openalex.org/W1547236510","https://openalex.org/W1547869235","https://openalex.org/W1969369083","https://openalex.org/W1979300931","https://openalex.org/W1987951694","https://openalex.org/W1988104415","https://openalex.org/W1993880501","https://openalex.org/W1997217004","https://openalex.org/W2013254767","https://openalex.org/W2047822138","https://openalex.org/W2065910438","https://openalex.org/W2074454485","https://openalex.org/W2075876517","https://openalex.org/W2083022489","https://openalex.org/W2092368843","https://openalex.org/W2096104385","https://openalex.org/W2135729119","https://openalex.org/W2164470216","https://openalex.org/W2253102682","https://openalex.org/W2338649218","https://openalex.org/W2341557816","https://openalex.org/W2343432909","https://openalex.org/W2395321879","https://openalex.org/W4293241248","https://openalex.org/W4298407707"],"related_works":["https://openalex.org/W2341557816","https://openalex.org/W2338649218","https://openalex.org/W2318772898","https://openalex.org/W2226490553","https://openalex.org/W2142195688","https://openalex.org/W2135729119","https://openalex.org/W2115170812","https://openalex.org/W2100082529","https://openalex.org/W2098506106","https://openalex.org/W2096104385","https://openalex.org/W2074454485","https://openalex.org/W2017416417","https://openalex.org/W1933587402","https://openalex.org/W1907938184","https://openalex.org/W1794992355","https://openalex.org/W1529388857","https://openalex.org/W1524381114","https://openalex.org/W2593892363","https://openalex.org/W1987951694","https://openalex.org/W2024933507"],"abstract_inverted_index":{"The":[0,78,225],"effect":[1],"of":[2,41,62,104,107,114,117,127,158,161,168,171,207,210,216,219,228,239],"granulocyte":[3],"colony-stimulating":[4],"factor":[5],"(G-CSF)":[6],"on":[7],"neutropenia,":[8],"infection,":[9],"and":[10,69,84,111,165,214],"cytotoxic":[11,229],"chemotherapy":[12,25,49,230],"administration":[13],"was":[14,231,283],"studied":[15],"in":[16,20,102,112,156,166,197,205,234,241,247,254,259,274,288,298,302,324,327],"a":[17,58,121,312],"randomized":[18,45,307],"trial":[19],"patients":[21,31,75,110,126,198,213,235,273,301,306],"receiving":[22,199,236],"intensive":[23],"weekly":[24],"for":[26,124,176],"non-Hodgkin's":[27],"lymphoma":[28],"(NHL).":[29],"Eighty":[30],"(aged":[32],"16":[33],"to":[34,46,73,143,308],"71":[35],"years)":[36],"with":[37,54,147,191,245,271],"high-grade":[38],"NHL":[39],"(Kiel)":[40],"any":[42],"stage":[43],"were":[44,71,187,203],"receive":[47,309],"VAPEC-B":[48],"alone":[50],"(39":[51],"patients)":[52],"or":[53,141,336],"G-CSF":[55,163,212,237,242,256,310],"administered":[56,72],"as":[57],"daily":[59],"subcutaneous":[60],"dose":[61,82,226,314],"230":[63],"micrograms/m2":[64],"(41":[65],"patients).":[66,249],"Prophylactic":[67],"ketoconazole":[68],"cotrimoxazole":[70],"all":[74],"throughout":[76],"treatment.":[77],"protocol":[79],"specified":[80],"identical":[81],"modification":[83],"antibiotic":[85,334],"treatment":[86,189],"criteria":[87],"bor":[88],"both":[89],"groups.":[90,341],"Neutropenia":[91],"(absolute":[92],"neutrophil":[93],"count":[94],"[ANC]":[95],"less":[96,150],"than":[97,140,151,297,316,331],"1.0":[98,152],"x":[99,153],"10(9)/L)":[100,154],"occurred":[101,155,253],"15":[103],"41":[105,159,208],"(37%)":[106],"the":[108,118,162,172,211,220,255,260,275,284,339],"G-CSF-treated":[109,276,289],"33":[113],"39":[115,169,217],"(85%)":[116],"controls,":[119],"giving":[120],"relative":[122],"risk":[123,175],"control":[125,248,261,317],"2.31":[128],"(95%":[129],"confidence":[130],"interval":[131],"[CI],":[132],"[1.51,":[133],"3.54];":[134],"P":[135,183,278],"=":[136,184,195,223,279],".00001).":[137],"Fever":[138],"(greater":[139],"equal":[142],"37.5":[144],"degrees":[145],"C)":[146],"neutropenia":[148,267],"(ANC":[149],"9":[157],"(22%)":[160],"group":[164,243,262],"17":[167],"(44%)":[170],"controls":[173,221,299],"(relative":[174],"control,":[177],"2.26;":[178],"95%":[179,240],"CI":[180],"[1.01,":[181],"5.06];":[182],".04).":[185],"There":[186],"fewer":[188],"delays,":[190],"shorter":[192],"duration":[193],"(P":[194,222],".01)":[196],"G-CSF.":[200],"Chemotherapy":[201],"doses":[202],"reduced":[204],"4":[206],"(10%)":[209],"13":[215],"(33%)":[218],".01).":[224],"intensity":[227,315],"significantly":[232],"increased":[233],"(median":[238],"compared":[244,270],"83%":[246],"Three":[250],"vascular":[251],"deaths":[252],"group.":[257],"Delays":[258],"most":[263],"commonly":[264],"resulted":[265],"from":[266],"(19":[268],"patients,":[269,290,318],"2":[272],"group,":[277],".000007).":[280],"Severe":[281],"mucositis":[282],"major":[285],"dose-limiting":[286],"toxicity":[287,329],"but":[291,319],"did":[292,321],"not":[293,322],"occur":[294],"more":[295],"frequently":[296],"(15":[300],"each":[303],"group).":[304],"Overall,":[305],"achieved":[311],"greater":[313],"this":[320],"result":[323],"significant":[325],"differences":[326],"drug":[328],"(other":[330],"neutropenia),":[332],"intravenous":[333],"usage,":[335],"hospitalization":[337],"between":[338],"two":[340]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}